Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.
Oxidative stress plays an important role in the pathogenesis of inflammatory bowel disease (IBD), including Crohn's disease (CrD). High levels of Reactive Oxygen Species (ROS) induce the activation of the redox-sensitive nuclear transcription factor kappa-B (NF-κB), which in turn triggers the i...
Main Authors: | Ilaria Russo, Alessandro Luciani, Paola De Cicco, Edoardo Troncone, Carolina Ciacci |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22412931/?tool=EBI |
Similar Items
-
Retraction: Butyrate Attenuates Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa through Modulation of Antioxidant Defense Machinery.
by: PLOS ONE Editors
Published: (2019-01-01) -
ER stress activation in the intestinal mucosa but not in mesenteric adipose tissue is associated with inflammation in Crohn's disease patients.
by: Andressa Coope, et al.
Published: (2019-01-01) -
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
by: Wang Yun-Jie, et al.
Published: (2010-03-01) -
Immunoproteomic to identify antigens in the intestinal mucosa of Crohn's disease patients.
by: Zheng Zhou, et al.
Published: (2013-01-01) -
Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease
by: Pooja S. Salvi, et al.
Published: (2021-07-01)